Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Inspect the solution regularly
DSIP is remarkably well-tolerated with minimal side effects when used under proper medical supervision with appropriate dosing protocols
Variations in study design, experimental conditions, and evaluation methods often lead to inconsistent or non comparable results across studies
First, phase II clinical trials evaluating MOTS-c in type 2 diabetes and sarcopenia are in development, and their results will provide the first randomized controlled evidence in humans to define therapeutic doses with statistical rigor
US$ 27.67
US$ 29.35
US$ 24.06
US$ 24.28
US$ 28.39
